While three sequencing efforts independently validated the presence of structural variants in AG genes and a recent study showed that the SLIT2-ROBO2 axis functions as a tumor suppressor in pancreas cancer, there have been no in vitro studies interrogating the impact of somatic AG gene mutations on pancreas cancer biology [9, 15–17]. Here, SLIT2 is linked to pancreatic neoplasm.